WELL:XETRA:XETRA-HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 20.235

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.43K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.05 (-0.10%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.01 (-0.07%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.09 (-0.32%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.07 (+0.23%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.08 (-0.32%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.29 (-0.62%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

+0.82 (+0.58%)

USD 102.09B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.03 (-0.06%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.59 (+0.56%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.26 (+0.53%)

USD 80.38B

ETFs Containing WELL:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.66% 76% C+ 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.66% 76% C+ 73% C
Trailing 12 Months  
Capital Gain 44.74% 94% A 93% A
Dividend Return 0.51% 4% F 5% F
Total Return 45.26% 94% A 93% A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 23.43% 93% A 91% A-
Dividend Return 23.47% 93% A 90% A-
Total Return 0.04% 5% F 3% F
Risk Return Profile  
Volatility (Standard Deviation) 23.38% 14% F 26% F
Risk Adjusted Return 100.37% 90% A- 91% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.